‘Invisible’ pharma firms short on reputation

New Jersey: Pharma companies that are less visible are also less likely to have favourable reputations, according to a US survey.

Pharma firms are the ‘most invisible’ among six industries that were surveyed, said Brad Fay, MD of Roper Public Affairs, the arm of NOP World that conducted the survey.

People familiar with the top firms were more likely to have a favourable impression of the industry; on a scale of one to ten, familiar respondents gave the industry a score of 7.9, while others gave it 6.2.

Awareness of drug firms has been falling, in part because of declining PR budgets and because of unbranded campaigns, according to Fay.

He added that pharma firms were more likely to be associated with profits than social responsibility.

A further finding of the survey was that healthcare was a top priority among 38 per cent of the public, coming in second only to concerns about terrorism.

‘We think this is a really dangerous time for pharma companies not to be engaged,’ Fay said.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in